Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes
Status:
Completed
Trial end date:
2019-07-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to examine, in a randomized controlled trial, the benefits and
costs of the American Heart Association's (AHA) advisory for depression screen and treatment
of post-acute coronary syndrome patients.
Phase:
N/A
Details
Lead Sponsor:
Columbia University
Collaborators:
Duke University HealthPartners Institute Kaiser Foundation Research Institute National Heart, Lung, and Blood Institute (NHLBI)